Biocon gets nod to enter into agreements with Pro-zeal Green Power Sixteen

08 Aug 2025 Evaluate

Biocon has received approval to enter into a power purchase agreement and share purchase/ subscription agreement/shareholders agreement with Pro-zeal Green Power Sixteen (PGPSPL) for purchase of solar power from captive off-site solar energy power plant and in this connection the company will be acquiring stake of 26% of paid-up share capital of PGPSPL. PGPSPL is engaged into the business of renewable energy generation.

The company will make investment of up to Rs 1.40 crore by partly acquiring equity shares of PGPSPL, representing 26% of its paid-up equity share capital, and partly by way of subscription to Compulsorily Convertible Debentures in one or more tranches as may be issued by PGPSPL.

The Board of Directors of the company at its meeting held August 07, 2025, had considered and approved the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

390.25 -5.00 (-1.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×